5F-ADB

Synthetic cannabinoid

5F-ADB
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

5F-ADB is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors and has been associated with numerous adverse health effects.

Chemical structure and properties

5F-ADB is chemically classified as an indazole-based synthetic cannabinoid. Its structure includes a 5-fluoropentyl chain, which is a common feature in many synthetic cannabinoids. The compound is a derivative of ADB-PINACA, with the addition of a fluorine atom on the pentyl chain.

Pharmacology

5F-ADB acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, memory, and pain sensation.

Effects

The effects of 5F-ADB are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, altered perception, and increased appetite. However, it can also cause severe adverse effects such as anxiety, paranoia, tachycardia, and in some cases, seizures or psychosis.

Legal status

Due to its potential for abuse and lack of medical use, 5F-ADB has been classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "new psychoactive substances".

Health risks

The use of 5F-ADB has been associated with numerous health risks. Acute intoxication can lead to severe cardiovascular and neurological effects. Chronic use may result in dependence and withdrawal symptoms. There have been reports of fatalities linked to the use of 5F-ADB, often in combination with other substances.

Synthesis

The synthesis of 5F-ADB involves the reaction of indazole with a fluoropentyl halide, followed by the addition of a carboxamide group. The process requires careful control of reaction conditions to ensure the correct isomer is produced.

Related pages

• Synthetic cannabinoid
• Cannabinoid receptor
• Endocannabinoid system
• Designer drug